Study to Evaluate the Safety and Efficacy of ASC41 in Overweight and Obese Subjects

NCT04686994 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

20

Enrollment

INDUSTRY

Sponsor class

Conditions

Overweight and Obesity
NAFLD
Hyperlipidemia

Interventions

DRUG: ASC 41
DRUG: ASC 41 Placebo

Sponsor

Gannex Pharma Co., Ltd.

Collaborators

[object Object]